Evidence map›Paper›PMID 39958876›Full record

ArticleNeuroImmune pharmacology and therapeutics2024

Something to talk about; crosstalk disruption at the neurovascular unit during HIV infection of the CNS.

Kalpani N Udeni Galpayage Dona, Mohammed M Benmassaoud, Cassandra D Gipson, Jay P McLaughlin, Servio H Ramirez, Allison M Andrews

Abstract read
In one paragraph

Article in NeuroImmune pharmacology and therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kalpani N Udeni Galpayage DonaDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Mohammed M BenmassaoudDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Cassandra D GipsonDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
Jay P McLaughlinDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Servio H RamirezDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Allison M AndrewsDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.ORCID https://orcid.org/0000-0003-1752-7450

Funding

The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapyR01DA052970 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI, RAMIREZ, SERVIO HEYBERT · 2021 to 2025
$3.0M
Synthetic fentanyls adversely affect the blood-brain barrier and HIV replication in the context of neuroHIVR01DA058536 · NIDA · UNIVERSITY OF FLORIDA · PI Allison Michelle Andrews, WENZHE HO · 2023 to 2026
$2.8M
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIVR01DA046833 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI POTULA, RAGHAVA, RAMIREZ, SERVIO HEYBERT · 2018 to 2022
$2.6M
HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular DiseaseDP2DA056172 · NIDA · UNIVERSITY OF FLORIDA · PI ANDREWS, ALLISON MICHELLE · 2022 to 2022
$2.3M
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance AbuseR61DA058397 · NIDA · UNIVERSITY OF FLORIDA · PI Allison Michelle Andrews, Pooja Jain · 2023 to 2026
$1.7M
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance AbuseK01DA046308 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ANDREWS, ALLISON MICHELLE · 2019 to 2023
$749k
NIDA NIH HHS DP2 DA056172NIDA NIH HHS K01 DA046308NIDA NIH HHS R01 DA046833NIDA NIH HHS R01 DA052970NIDA NIH HHS R01 DA058536NIDA NIH HHS R61 DA058397
6 · The paper itself

Abstract

Although treatable with antiretroviral therapy, HIV infection persists in people living with HIV (PLWH). It is well known that the HIV virus finds refuge in places for which antiretroviral medications do not reach therapeutic levels, mainly the CNS. It is clear that as PLWH age, the likelihood of developing HIV-associated neurological deficits increases. At the biochemical level neurological dysfunction is the manifestation of altered cellular function and ineffective intercellular communication. In this review, we examine how intercellular signaling in the brain is disrupted in the context of HIV. Specifically, the concept of how the blood-brain barrier can be a convergence point for crosstalk, is explored. Crosstalk between the cells of the neurovascular unit (NVU) (endothelium, pericytes, astrocytes, microglia and neurons) is critical for maintaining proper brain function. In fact, the NVU allows for rapid matching of neuronal metabolic needs, regulation of blood-brain barrier (BBB) dynamics for nutrient transport and changes to the level of immunosurveillance. This review invites the reader to conceptually consider the BBB as a router or convergence point for NVU crosstalk, to facilitate a better understanding of the intricate signaling events that underpin the function of the NVU during HIV associated neuropathology.

Indexed as

blood-brain barrierendothelial cellsintercellularneurovascular unit

Identifiers

PMID39958876
PMCPMC11823645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.